Efficacy and safety of GMRx2 (a single pill combination containing telmisartan/amlodipine/indapamide) compared to placebo for the treatment of hypertension: An international, multi-center, randomized, double-blind, placebo-controlled, parallel-group trial - Trial SLCTR_2023_009
Access comprehensive clinical trial information for SLCTR_2023_009 through Pure Global AI's free database. This Phase 3 trial is sponsored by George Medicines Pty Limited and is currently Recruiting. The study focuses on Hypertension.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2023_009
Phase 3
Recruiting
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2023_009
Efficacy and safety of GMRx2 (a single pill combination containing telmisartan/amlodipine/indapamide) compared to placebo for the treatment of hypertension: An international, multi-center, randomized, double-blind, placebo-controlled, parallel-group trial
Study Focus
Interventional
Sponsor & Location
George Medicines Pty Limited
Australia;Nigeria;Sri Lanka;United Kingdom;United States of America
Timeline & Enrollment
Phase 3
Jul 01, 2023
N/A
ICD-10 Classifications
Hypertensive diseases
Renovascular hypertension
Secondary hypertension
Other secondary hypertension
Hypertensive heart disease
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2023_009
Non-Device Trial